Ophthalmology

Latest News

old woman eye
Samsung Bioepis Shares 1-Year Phase 3 Results for Eylea Biosimilar

May 2nd 2023

At the 2023 Association for Research in Vision and Ophthalmology Annual Meeting, Samsung Bioepis shared comparable safety, efficacy, and immunogenicity data through 1 year between its aflibercept biosimilar (SB15) and the originator (Eylea).

eye cross section
Biosimilar Ranibizumab Displays Comparable Safety, Efficacy to Lucentis

April 28th 2023

biosimilar check in banner
Biosimilars Check In: Vegzelma Launch, BLA Acceptances, China Approval

April 26th 2023

eye health
SB11 Demonstrates Biosimilarity to Lucentis in Long-term Study in nAMD

April 22nd 2023

Computerized close-up of an eye | Image credit: Ayesha  - stock.adobe.com.
Real-World Study Suggests Comparable Efficacy Between Biosimilar Razumab and Originator in PCV

April 15th 2023

Video Interviews
Podcasts
"SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars" with the CfB logo and an image of an eye
CfB podcast banner
CfB podcast banner
CfB podcast banner

More News

© 2023 MJH Life Sciences

All rights reserved.